Grimes & Company »

Rocket Pharmaceuticals shares owned by Grimes & Company

Quarter-by-quarter ownership of Rocket Pharmaceuticals (RCKT) shares owned by Grimes & Company from 13F filings

Historical chart of Grimes & Company investment in Rocket Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Rocket Pharmaceuticals held by Grimes & Company consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Rocket Pharmaceuticals by Grimes & Company

Quarter filed Position value Share count Share price at filing
2025-12-31 $44k 13k 3.51
2025-09-30 $50k 15k 3.26

More positions owned by Grimes & Company

Ishares Tr Core Msci Eafe (IEFA)
Vanguard Index Fds Small Cp Etf (VB)
Ishares Tr Core S&p500 Etf (IVV)
Spdr Series Trust State Street Spd (SJNK)
Ishares Tr Broad Usd High (USHY)
Spdr Series Trust State Street Spd (SPHY)
Ishares Core Msci Emkt (IEMG)
Select Sector Spdr Tr State Street Tec (XLK)
John Hancock Exchange Traded Mltfctr Lrg Cap (JHML)
Apple (AAPL)
Microsoft Corporation (MSFT)
Select Sector Spdr Tr State Street Com (XLC)
Select Sector Spdr Tr State Street Hea (XLV)
NVIDIA Corporation (NVDA)
Vanguard Index Fds Growth Etf (VUG)

View all positions for Grimes & Company

Top funds holding Rocket Pharmaceuticals

Rtw Investments
Vanguard Group
BlackRock
Suvretta Capital Management
Monaco Asset Management SAM
Newtyn Management
D. E. Shaw & Co
Maverick Capital
Two Sigma Investments
Geode Capital Management
Two Sigma Advisers
Millennium Management
State Street Corporation
MPM Oncology Impact Management
Citadel Advisors

View all funds holding Rocket Pharmaceuticals